124 related articles for article (PubMed ID: 7205885)
1. Potential antitumor agents. 34. Quantitative relationships between DNA binding and molecular structure for 9-anilinoacridines substituted in the anilino ring.
Baguley BC; Denny WA; Atwell GJ; Cain BF
J Med Chem; 1981 Feb; 24(2):170-7. PubMed ID: 7205885
[TBL] [Abstract][Full Text] [Related]
2. [Quenching of ethidium-DNA fluorescence by novel acridines with antitumor activities].
Kimura M
Yakugaku Zasshi; 1992 Dec; 112(12):914-8. PubMed ID: 1294716
[TBL] [Abstract][Full Text] [Related]
3. [Quenching of ethidium-DNA fluorescence by novel acridines with antitumor activities. II. The structure-activity relationship in acridines with fluorescence quenching of ethidium-DNA].
Kimura M; Inoue H; Uchitubo T; Kojima H; Okabayashi I
Yakugaku Zasshi; 1993 Jun; 113(6):454-9. PubMed ID: 8355147
[TBL] [Abstract][Full Text] [Related]
4. Potential antitumor agents. 26. Anionic congeners of the 9-anilinoacridines.
Denny WA; Atwell GJ; Cain BF
J Med Chem; 1978 Jan; 21(1):5-10. PubMed ID: 619148
[TBL] [Abstract][Full Text] [Related]
5. Interactions of anilinoacridines with nucleic acids: effects of substituent modifications on DNA-binding properties.
Wadkins RM; Graves DE
Biochemistry; 1991 Apr; 30(17):4277-83. PubMed ID: 2021620
[TBL] [Abstract][Full Text] [Related]
6. Potential antitumor agents. 29. Quantitative structure-activity relationships for the antileukemic bisquaternary ammonium heterocycles.
Denny WA; Atwell GJ; Baguley BC; Cain BF
J Med Chem; 1979 Feb; 22(2):134-50. PubMed ID: 423193
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2.
Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP
Biochemistry; 1999 Jul; 38(29):9221-33. PubMed ID: 10413496
[TBL] [Abstract][Full Text] [Related]
8. Potential antitumor agents. 35. Quantitative relationships between antitumor (L1210) potency and DNA binding for 4'-(9-acridinylamino)methanesulfon-m-anisidide analogues.
Baguley BC; Denny WA; Atwell GJ; Cain BF
J Med Chem; 1981 May; 24(5):520-5. PubMed ID: 6894620
[TBL] [Abstract][Full Text] [Related]
9. Electron donor properties of the antitumour drug amsacrine as studied by fluorescence quenching of DNA-bound ethidium.
Davis LM; Harvey JD; Baguley BC
Chem Biol Interact; 1987; 62(1):45-58. PubMed ID: 3581286
[TBL] [Abstract][Full Text] [Related]
10. Redox chemistry of the 9-anilinoacridine class of antitumor agents.
Jurlina JL; Lindsay A; Packer JE; Baguley BC; Denny WA
J Med Chem; 1987 Mar; 30(3):473-80. PubMed ID: 3820217
[TBL] [Abstract][Full Text] [Related]
11. 9-substituted acridine derivatives with long half-life and potent antitumor activity: synthesis and structure-activity relationships.
Su TL; Chou TC; Kim JY; Huang JT; Ciszewska G; Ren WY; Otter GM; Sirotnak FM; Watanabe KA
J Med Chem; 1995 Aug; 38(17):3226-35. PubMed ID: 7650675
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of tricyclic compounds with anilino substituents and their intercalation complexes with DNA sequences.
Loza-Mejía MA; Castillo R; Lira-Rocha A
J Mol Graph Model; 2009; 27(8):900-7. PubMed ID: 19269869
[TBL] [Abstract][Full Text] [Related]
13. Novel acridine-triazenes as prototype combilexins: synthesis, DNA binding, and biological activity.
McConnaughie AW; Jenkins TC
J Med Chem; 1995 Sep; 38(18):3488-501. PubMed ID: 7658436
[TBL] [Abstract][Full Text] [Related]
14. Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents.
Denny WA; Cain BF; Atwell GJ; Hansch C; Panthananickal A; Leo A
J Med Chem; 1982 Mar; 25(3):276-315. PubMed ID: 7069706
[TBL] [Abstract][Full Text] [Related]
15. The relationship between frameshift mutagenicity and DNA-binding affinity in a series of acridine-substituted derivatives of the experimental antitumour drug 4'-(9-acridinylamino)methanesulphonanilide (AMSA).
Ferguson LR; Baguley BC
Mutat Res; 1981 Jun; 82(1):31-9. PubMed ID: 7022171
[TBL] [Abstract][Full Text] [Related]
16. DNA Bifunctional intercalators. 2. Fluorescence properties and DNA binding interaction of an ethidium homodimer and an acridine ethidium heterodimer.
Gaugain B; Barbet J; Capelle N; Roques BP; Le Pecq JB
Biochemistry; 1978 Nov; 17(24):5078-88. PubMed ID: 569495
[TBL] [Abstract][Full Text] [Related]
17. Potential antitumor agents. 39. Anilino ring geometry of amsacrine and derivatives: relationship to DNA binding and antitumor activity.
Denny WA; Atwell GJ; Baguley BC
J Med Chem; 1983 Nov; 26(11):1625-30. PubMed ID: 6688830
[TBL] [Abstract][Full Text] [Related]
18. Quenching of DNA-ethidium fluorescence by amsacrine and other antitumor agents: a possible electron-transfer effect.
Baguley BC; Le Bret M
Biochemistry; 1984 Feb; 23(5):937-43. PubMed ID: 6546881
[TBL] [Abstract][Full Text] [Related]
19. Electron-deficient DNA-intercalating agents as antitumor drugs: aza analogues of the experimental clinical agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Chen Q; Deady LW; Baguley BC; Denny WA
J Med Chem; 1994 Mar; 37(5):593-7. PubMed ID: 8126699
[TBL] [Abstract][Full Text] [Related]
20. Energetics and stereochemistry of DNA complexation with the antitumor AT specific intercalators tilorone and m-AMSA.
Chen KX; Gresh N; Pullman B
Nucleic Acids Res; 1988 Apr; 16(7):3061-73. PubMed ID: 3368315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
